Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

NCT01181999 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Large B-cell, Diffuse

Interventions

DRUG: rituximab

Sponsor

Chonnam National University Hospital

Collaborators

[object Object]
[object Object]
[object Object]